Lv1
30 积分 2025-01-23 加入
Approaches for posaconazole therapeutic drug monitoring and their clinical benefits
22天前
已完结
A Population Pharmacokinetic Modeling and Simulation Study of Posaconazole Oral Suspension in Immunocompromised Pediatric Patients: A Short Communication
26天前
已完结
Dosing of IV posaconazole to treat critically ill patients with invasive pulmonary aspergillosis: a population pharmacokinetics modelling and simulation study
26天前
已完结
Model‐Informed Dose Justifications of Posaconazole in Japanese Patients for Prophylaxis and Treatment Against Fungal Infection
26天前
已完结
Dosing of IV posaconazole to treat critically ill patients with invasive pulmonary aspergillosis: a population pharmacokinetics modelling and simulation study
26天前
已关闭
Population pharmacokinetic model‐guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction
27天前
已完结
Evaluation of posaconazole plasma concentrations achieved with the delayed‐release tablets in Korean high‐risk patients with haematologic malignancy
1个月前
已完结
Therapeutic drug monitoring following crushed administration of delayed-release posaconazole tablets via enteral feeding tubes
1个月前
已完结
Therapeutic drug monitoring of posaconazole delayed release tablet while managing COVID‐19–associated mucormycosis in a real‐life setting
1个月前
已完结
Factors Associated With Voriconazole Concentration in Pediatric Patients
1个月前
已完结
皖公网安备34019202002308
